Literature DB >> 20600869

Radical changes in multiple sclerosis pathogenesis.

Jack van Horssen1, Maarten E Witte, Gerty Schreibelt, Helga E de Vries.   

Abstract

Reactive oxygen species (ROS) contain one or more unpaired electrons and are formed as intermediates in a variety of normal biochemical reactions. However, when generated in excess amounts or not appropriately controlled, ROS initiate extensive cellular damage and tissue injury. ROS have been implicated in the progression of cancer, cardiovascular disease and neurodegenerative and neuroinflammatory disorders, such as multiple sclerosis (MS). In the last decade there has been a major interest in the involvement of ROS in MS pathogenesis and evidence is emerging that free radicals play a key role in various processes underlying MS pathology. To counteract ROS-mediated damage, the central nervous system is equipped with an intrinsic defense mechanism consisting of endogenous antioxidant enzymes. Here, we provide a comprehensive overview on the (sub)cellular origin of ROS during neuroinflammation as well as the detrimental effects of ROS in processing underlying MS lesion development and persistence. In addition, we will discuss clinical and experimental studies highlighting the therapeutic potential of antioxidant protection in the pathogenesis of MS. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600869     DOI: 10.1016/j.bbadis.2010.06.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  96 in total

Review 1.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

2.  Relationship between thiol-disulphide homeostasis and visual evoked potentials in patients with multiple sclerosis.

Authors:  Gönül Vural; Şadiye Gümüşyayla; Orhan Deniz; Salim Neşelioğlu; Özcan Erel
Journal:  Neurol Sci       Date:  2018-12-01       Impact factor: 3.307

Review 3.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

Review 4.  Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.

Authors:  Hans Lassmann
Journal:  J Neural Transm (Vienna)       Date:  2011-03-05       Impact factor: 3.575

5.  Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage.

Authors:  Junli Liu; Daishi Tian; Madhuvika Murugan; Ukpong B Eyo; Cheryl F Dreyfus; Wei Wang; Long-Jun Wu
Journal:  J Neurochem       Date:  2015-08-11       Impact factor: 5.372

6.  Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Dragan Stojanov; Svetlana Stojanovic; Gordana Kocic; Dejan Savic; Tatjana Cvetkovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.046

Review 7.  Myeloid cells - targets of medication in multiple sclerosis.

Authors:  Manoj K Mishra; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

Review 8.  Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction.

Authors:  P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 9.  Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis.

Authors:  Carin Waslo; Dennis Bourdette; Nora Gray; Kirsten Wright; Rebecca Spain
Journal:  Curr Treat Options Neurol       Date:  2019-05-06       Impact factor: 3.598

10.  Role of autophagy in the pathogenesis of multiple sclerosis.

Authors:  Peizhou Liang; Weidong Le
Journal:  Neurosci Bull       Date:  2015-08-08       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.